Structure Info
- Chemspace ID
- CSSS00000051173 (In-Stock Screening Compounds)
- CAS
- 184475-35-2
- MFCD
- MFCD04307832
- IUPAC Name
- N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine
- Mol formula
- C22H24ClFN4O3
- Mol weight
- 447 Da
- Catalog Number(s)
- 10496, 13166, 21432, 101029, 306578, 34a_100015190902_100000748698, 37923, A109874, A8219, AA0039I6, AB52186, ACM184475352, ACM184475352-2, ACS-524, ADB92939001, AG0039KY, AJ52186, AOS0039KY, APB184475352, AR003A9Y, ArZ-UP080933, ArZ-UP480321, B0084-306578, BB4LS-EN300-123024, BBF-04570, BD131918, BG164498, BISN0101, CB14314, CD31002885, CFN90011, CSC000051173, CT1946, DZB66449, EN300-123024, F079438, F231003, FG10816, G0546, G304000, H018, HY-50895, J10250, J94474, KS-1204, LAN-B42345, LN00175798, LQT-B42422, M12848, OSSL_882918, R633575, S1025, SAB-025327, SC-18023, SM00066, STK621310, SY002154, SYN1042, T1181, YBD160510, Z1546610485, Z1551429741, ZX-AE020634, ZX-CY002097, scs-524
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.75
- Heavy atoms count
- 31
- Rotatable bond count
- 8
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.363
- Polar surface area (Å)
- 69
- Hydrogen bond acceptors count
- 7
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSSS00000051173
Items Overall 36 items from 8 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
Enamine Ltd | 5 days | Ukraine To: | 90 | 1 mg | 83 | |
Enamine Ltd | 5 days | Ukraine To: | 90 | 2 mg | 85 | |
Enamine Ltd | 5 days | Ukraine To: | 90 | 5 mg | 91 | |
Enamine Ltd | 5 days | Ukraine To: | 90 | 10 mg | 102 | |
Enamine Ltd | 5 days | Ukraine To: | 90 | 20 mg | 123 | |
MedChemExpress | 10 days | United States To: | 99 | 100 mg | 60 | |
MedChemExpress | 10 days | United States To: | 99 | 500 mg | 72 | |
MedChemExpress | 10 days | United States To: | 99 | 1 g | 90 | |
MedChemExpress | 10 days | United States To: | 99 | 5 g | 180 | |
MedChemExpress | 10 days | United States To: | 99 | 10mM/1mL | 66 | |
Description: Names: Gefitinib; ZD1839; Product Description: Gefitinib (ZD1839) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC 50 of 33 nM. Gefitinib selectively inhibits EGF-stimulated tumor cell growth (IC 50 of 54 nM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib also induces autophagy and cell apoptosis , which can be used for cancer related research, such as Lung cancer and breast cancer .; Target: Apoptosis;Autophagy;EGFR; CAS: 184475-35-2 | ||||||
Apexbio Technology LLC | 10 days | United States To: | 99 | 100 mg | 67 | |
Apexbio Technology LLC | 10 days | United States To: | 99 | 250 mg | 77 | |
Apexbio Technology LLC | 10 days | United States To: | 99 | 10mM (in 1mL DMSO) | 61 | |
Description: Name: Gefitinib (ZD1839); Selective EGFR inhibitor; Format: a solid; CAS: 184475-35-2 | ||||||
Key Organics Limited (BIONET) | 10 days | United Kingdom To: | 97 | 1 mg | 61 | |
Key Organics Limited (BIONET) | 10 days | United Kingdom To: | 97 | 5 mg | 92 | |
Key Organics Limited (BIONET) | 10 days | United Kingdom To: | 97 | 10 mg | 128 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 100 mg | 63 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 500 mg | 75 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 1 g | 95 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 5 g | 190 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 10mM/1mL | 69 | |
Description: Names: Gefitinib; ZD1839; Product Description: Gefitinib (ZD1839) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib also induces autophagy and cell apoptosis, which can be used for cancer related research, such as Lung cancer and breast cancer ; Target: Apoptosis;Autophagy;EGFR; CAS: 184475-35-2 | ||||||
Princeton Biomolecular Research | 10 days | United States To: | 90 | 1 mg | 88 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 2 mg | 94 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 5 mg | 99 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 10 mg | 116 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 15 mg | 132 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 20 mg | 143 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 50 mg | 231 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 100 mg | 297 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 3 umol | 94 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 5 umol | 99 | |
ChemFaces | 12 days | China To: | 90 | 1 mg | 6 | |
Description: CAS: 184475-35-2 | ||||||
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 100 mg | 50 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 500 mg | 57 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 1 g | 74 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 5 g | 148 | |
Description: Gefitinib (ZD1839) is an EGFR first-generation inhibitor with oral activity that inhibits the EGFR 19 Del and L858R mutations. Gefitinib has antitumor activity and is used for the treatment of EGFR-mutated non-small-cell lung cancers. Gefitinib administration RESULTS in the development of the EGFR C797S resistance mutation.; CAS: 184475-35-2 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire